CAS: 42055-15-2; 3-(Methylamino)Propan-1-Ol

该化合物是一种多用途有机化合物,具有氢氧基和甲基氨基功能组,在制药和化学合成中作为中间体很有价值,其双功能结构使活性药物成分(APIs),腐蚀抑制剂和特殊表面活性剂的生产能够应用.该化合物在极地溶剂中表现出良好的溶解性,促进了其在水体和有机反应系统中的使用.它的主要矿泉水和酒精糖允许进一步衍生,提高了其在精细化学制造中的效用.3-(甲基乙基氨)丙醇具有明确界定的分子结构,提供了一致的再活动,为需要精确功能组变的研究和工业过程提供了可靠的选择.

结构式图片

相似化合物

157887-82-6 58885-58-8 89448-83-9

欧盟法规

ECHA物质C&L通报

上下游产品

trimethylene oxide methylamine methyl-carbamic acid-(3-chloro-propyl ester) allyl alcohol -3-methyl-2H-1,3,2-oxazaphosphorinan-1-oxid2--3-methyl-2H-1,3,2-oxazaphosphorinan-1-oxid N-methyl-N-nitroso-3-hydroxypropylamine -propanol-(1)3-3-Phenyl-1-methyl-thioureido-propanol-(1) (3-Hydroxy-propyl)-methyl-prop-2-inyl-amin

合成工艺路线路线简述

    3-氯-1-丙醇置于sodium Iodide 甲胺,Potassium Carbonate体系中,用 水 作为反应溶剂,化学反应 17.0H,反应生成 3-(甲胺基)-1-丙醇
    参考文献:Process For Preparation Of Substituted Amino Alcohols
    标题:Process For Preparation Of Substituted Amino Alcohols
    摘要:提供了一种制备取代氨基醇ho-(Ch2)N-nr1R2的过程,其中x为cl,Br或i的卤代醇ho-(Ch2)N-x与胺hnr1R2在水中作作为反应溶剂反应,反应温度范围为约20oc到约90°C,在需要时可在碘化物源金属碘化物的催化下进行.卤代醇在制备6-[(取代)苯基]-三唑嘧啶化合物中有用,该化合物在癌症治疗中有用.

    海关参考信息

    专利信息


    专利号:US-6846957-B2
    优先权日:2002-11-22
    标题 :Synthesis of 3-aminomethyl-1-propanol, a fluoxetine precursor
    发明人:ZELENIN ALEXANDER
    权利人:UNIV TEXAS
    摘要:The present invention concerns a method of synthesizing fluoxetine hydrochloride. The method includes the synthesis of 3-methylamino-1-phenyl-1-propanol by reduction of 1-phenyl-3-methylamino-2-propen-1-one with sodium borohydride and acetic acid.

    专利号:US-8304409-B2
    优先权日:2002-07-03
    标 题:Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
    发明人:EARL RICHARD A; EZAWA MAIKO; FANG XINQIN; GARVEY DAVID S; GASTON RICKY D; KHANAPURE SUBHASH P; LETTS L GORDON; LIN CHIA-EN; RANATUNGE RAMANI R; RICHARDSON STEWART K; SCHROEDER JOSEPH D; STEVENSON CHERI A; WEY SHIOW-JYI
    权利人:EARL RICHARD A; EZAWA MAIKO; FANG XINQIN; GARVEY DAVID S; GASTON RICKY D; KHANAPURE SUBHASH P; LETTS L GORDON; LIN CHIA-EN; RANATUNGE RAMANI R; RICHARDSON STEWART K; SCHROEDER JOSEPH D; STEVENSON CHERI A; WEY SHIOW-JYI; NICOX SA
    摘要:The invention describes novel nitrosated nonsteroidal antiinflammatory drugs (NSAIDs) and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitrosated NSAID, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The invention also provides novel compositions comprising at least one nitrosated NSAID, and at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The invention also provides novel kits comprising at least one nitrosated NSAID, and, optionally, at least one nitric oxide donor and/or at least one therapeutic agent. The invention also provides methods for treating inflammation, pain and fever; for treating gastrointestinal disorders; for facilitating wound healing; for treating and/or preventing gastrointestinal, renal and/or respiratory toxicities resulting from the use of nonsteroidal antiinflammatory compounds; for treating inflammatory disease states and/or disorders; and for treating and/or preventing ophthalmic diseases and/or disorders.

    专利号:US-12337036-B2
    优先权日:2018-01-01
    标题:Compounds and methods for trans-membrane delivery of molecules
    发明人:ZIV ILAN; GRIMBERG HAGIT; DUBROVSKY JOSEPH
    权利人:APOSENSE LTD
    摘要:The Invention provides a novel delivery system for delivery of drugs across biological membranes. It provides novel chemical conjugates that comprise said delivery system, methods for synthesis of said compounds, and methods for utilization of said delivery system, among others, for delivery of genetic drugs into tissues and cells, in vitro, ex vivo, and in vivo, for the treatment of various medical disorders.

    专利号:US-9056887-B2
    优先权日:2011-07-26
    标 题 :Minor groove binder phosphoramidites and methods of use
    发明人:VOROBIEV ALEXEI; LUKHTANOV EUGENY A
    权利人:VOROBIEV ALEXEI; LUKHTANOV EUGENY A; ELITECH HOLDING BV
    摘要:Minor groove binder phosphoramidites having the formula M-L-PA, wherein M is a minor groove binder comprising a protected heteroaromatic amine, L is a linker, and PA is a phosphoramidite group, have been synthesized. Preferred methods of synthesis include synthesizing a minor groove binder intermediate containing a transiently protected hydroxyl group, protecting heteroaromatic amines of the corresponding minor groove binder intermediate as carbamate intermediates, reacting the carbamate intermediate to remove the transient protecting group to yield carbamate-protected minor groove binder agent as an intermediate with a free hydroxyl group, and converting the intermediate with a free hydroxyl group to the desired minor groove binder phosphoramidite. These minor groove binder phosphoramidites are useful in the preparation of oligonucleotide conjugates, particularly those for use as probes and primers. In preferred methods, an oligonucleotide sequence is synthesized using nucleoside phosphoramidites and the minor groove binder phosphoramidite is incorporated into the oligonucleotide sequence to form a protected oligonucleotide-minor groove binder conjugate. Then, deprotection produces the oligonucleotide-minor groove binder.

    专利号:DE-60302664-T2
    优先权日:2002-06-12
    标题:SYNTHESIS OF SILICOALUMOPHOSPHATES

    专利号:US-2007043234-A1
    优先权日:2003-07-09
    标 题 :Use of functionalized onium salts as a soluble support for organic synthesis
    扬州市普林斯化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.princechem.com
    企业联系电话:0514-84248359;13328140016👤
    📞扬州市普林斯化工有限公司 ⚠️参考联系方式
    联系人:瞿军
    电话:0514-84248359;13328140016
    手机:13328140016
    传真:0514-84248778
    邮箱:sales@princechem.com
    通信地址: 扬州市高新区吉安南路136号
    邮编: 225654
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:扬州市高新区吉安南路136号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    济南大宇化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.jinandayuchem.com
    企业联系电话:0531-87153728👤
    📞济南大宇化工有限公司 ⚠️参考联系方式
    联系人:徐经理
    电话:0531-87153728
    手机:13805401165
    传真:0531-87922099
    邮箱:xufeng192@126.com xufeng192@jinandayuchem.com
    通信地址: 济南市天桥区新材料交易产业园区西副楼
    邮编: 250022
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:济南市天桥区新材料交易产业园区西副楼
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    扬州市普林斯医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.princechem.cn
    企业联系电话:吴宇皓18752736070,郭跃18936227980👤
    📞扬州市普林斯医药科技有限公司 ⚠️参考联系方式
    联系人:吴宇皓;郭跃
    电话:吴宇皓18752736070,郭跃18936227980
    手机:吴宇皓18752736070

    邮箱:david@princechem.com;remi@princechem.com;chen@princechem.com
    通信地址: 扬州市高新技术开发区吉安南路158号金荣科技园B8栋6楼
    邮编: 225000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:扬州市高新技术开发区吉安南路158号金荣科技园B8栋6楼
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances[Online], Thieme: Stuttgart, (2003).
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知